Dashboard
Manage Tickers

EVH Evolent Health, Inc.

NYSE evolenthealth.com


$ 4.12 $ 0.02 (0.48 %)    

Friday, 14-Nov-2025 15:54:55 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 4.18
$ 4.03
$ 4.14 x 538
$ 4.13 x 2,973
$ 4.01 - $ 4.30
$ 4.01 - $ 13.62
6,199,311
na
466.49M
$ 0.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-20-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-23-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-28-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-05-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-01-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-03-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-16-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-evolent-health-lowers-price-target-to-9
Canaccord Genuity Maintains Buy on Evolent...
11/14/2025 17:41:13

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $16 ...

bmo-capital-initiates-coverage-on-evolent-health-with-outperform-rating-announces-price-target-of-7
BMO Capital Initiates Coverage On Evolent ...
11/13/2025 10:47:52

BMO Capital analyst Sean Dodge initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price ...

oppenheimer-maintains-outperform-on-evolent-health-lowers-price-target-to-12
Oppenheimer Maintains Outperform on Evolen...
11/12/2025 16:23:51

Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and lowers the price target fro...

truist-securities-maintains-buy-on-evolent-health-lowers-price-target-to-10
Truist Securities Maintains Buy on Evolent...
11/10/2025 16:38:22

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $1...

citizens-maintains-market-outperform-on-evolent-health-lowers-price-target-to-11
Citizens Maintains Market Outperform on Ev...
11/10/2025 13:44:58

Citizens analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform and lowers the price targe...

btig-maintains-buy-on-evolent-health-lowers-price-target-to-16
BTIG Maintains Buy on Evolent Health, Lowe...
11/07/2025 19:55:26

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $20 to $16.

evolent-health-american-oncology-network-announce-new-model-to-enhance-cancer-care
Evolent Health, American Oncology Network ...
11/06/2025 21:41:32

Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and...

evolent-health-appoints-mario-ramos-cfo-effective-jan-1
Evolent Health Appoints Mario Ramos CFO, E...
11/06/2025 21:31:26

SEC

evolent-health-raises-fy2025-sales-guidance-from-1850b-1880b-to-1870b-1880b-vs-1884b-est
Evolent Health Raises FY2025 Sales Guidanc...
11/06/2025 21:13:21

Evolent Health (NYSE:EVH) raises FY2025 sales outlook from $1.850 billion-$1.880 billion to $1.870 billion-$1.880 billion vs $1...

evolent-health-sees-q4-sales-462000m-472000m-vs-481406m-est
Evolent Health Sees Q4 Sales $462.000M-$47...
11/06/2025 21:12:59

Evolent Health (NYSE:EVH) sees Q4 sales of $462.000 million-$472.000 million vs $481.406 million analyst estimate.

evolent-health-q3-adj-eps-005-misses-011-estimate-sales-479533m-beat-473745m-estimate
Evolent Health Q3 Adj. EPS $0.05 Misses $0...
11/06/2025 21:12:33

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.11 b...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

forecasting-the-future-6-analyst-projections-for-evolent-health
Forecasting The Future: 6 Analyst Projecti...
09/30/2025 12:02:03

btig-reiterates-buy-on-evolent-health-maintains-20-price-target
BTIG Reiterates Buy on Evolent Health, Mai...
09/30/2025 10:51:17

BTIG analyst David Larsen reiterates Evolent Health (NYSE:EVH) with a Buy and maintains $20 price target.

privia-health-acquires-evolents-aco-business-to-boost-value-based-care
Privia Health Acquires Evolent's ACO Busin...
09/24/2025 17:38:35

Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint.

stephens--co-reiterates-equal-weight-on-evolent-health-maintains-9-price-target
Stephens & Co. Reiterates Equal-Weight on ...
09/24/2025 12:28:53

Stephens & Co. analyst Jeff Garro reiterates Evolent Health (NYSE:EVH) with a Equal-Weight and maintains $9 price target.

evolent-health-affirms-q3-sales-guidance-of-460000m-480000m-vs-473745m-est
Evolent Health Affirms Q3 Sales Guidance o...
09/23/2025 21:36:24

Evolent Health (NYSE:EVH) affirms Q3 sales outlook from $460.000 million-$480.000 million to $460.000 million-$480.000 million ...

evolent-health-affirms-fy2025-sales-guidance-of-1850b-1880b-vs-1884b-est
Evolent Health Affirms FY2025 Sales Guidan...
09/23/2025 21:36:15

Evolent Health (NYSE:EVH) affirms FY2025 sales outlook from $1.850 billion-$1.880 billion to $1.850 billion-$1.880 billion vs $...

Core News & Articles
Evolent Announces Divestiture Of Its Evole...
09/23/2025 20:11:56

the-analyst-verdict-evolent-health-in-the-eyes-of-4-experts
The Analyst Verdict: Evolent Health In The...
09/09/2025 12:01:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION